By Terri Rimmer
Two or three quick steps is all it takes for physicians to enroll their patients in an assistance program for medications.
With Rx Hope (rxhope.com) red tape is cut to smithereens allowing for less application processing time, according to Christine Maris, CEO and site manager of Rx Hope.
“We have online applications so the doctor can log on to the site or some clients actually pay the site to do the service,” she said. “Requests from patients double monthly and are growing steadily.”
The site has the entire doctor’s information so the nurse only has to look for a DEA number on the site which is updated regularly. Each drug order comes with a tracking number and patients can print out applications online. Everything is up to date and patients can also print out information for their doctor.
“It saves time,” said Maris.
The Clinton, NJ company is the only patient assistance Internet initiative supported by PHRMA and participating drug companies. Rx Hope started as a grassroots project of the Patient Assistance Program and Directors of the PHRMA-member businesses and has achieved leading Internet-based patient help and sampling of the medication world.
Each patient assistance request form is tailor-made by the medication company’s regulations search. Rx Hope is an independent company not associated with others who provide patients with low or no-cost meds. According to their website, one of the benefits of using the service is a financial savings due to less money spent on postage, printing, sorting, and other lengthy jobs. Rx Hope, a privately held company, also has an assistance finder which joins info compared with other current federal, state, and other pharmaceutical models.
One drug, Requip (Ropinirole HCL), a medication for insomnia which was approved on May 9th, is popular for the treatment of primary Restless Leg Syndrome (RLS) in adults. Symptoms include an uncomfortable feeling in the legs (tingling, creepy, itching, pulling, or aching) with an urge to move them during inactivity, including both sleep and wakefulness. The cause of RLS is unknown but researchers believe it may be related to dopamine, a chemical that carries signals between nerve cells. The approval of the drug for came after clinical trials showed it greatly reduced symptoms and improved sleep quality in adults.
For more information, call 908-713-7600 or email customerservice@rxhope.com.
Two or three quick steps is all it takes for physicians to enroll their patients in an assistance program for medications.
With Rx Hope (rxhope.com) red tape is cut to smithereens allowing for less application processing time, according to Christine Maris, CEO and site manager of Rx Hope.
“We have online applications so the doctor can log on to the site or some clients actually pay the site to do the service,” she said. “Requests from patients double monthly and are growing steadily.”
The site has the entire doctor’s information so the nurse only has to look for a DEA number on the site which is updated regularly. Each drug order comes with a tracking number and patients can print out applications online. Everything is up to date and patients can also print out information for their doctor.
“It saves time,” said Maris.
The Clinton, NJ company is the only patient assistance Internet initiative supported by PHRMA and participating drug companies. Rx Hope started as a grassroots project of the Patient Assistance Program and Directors of the PHRMA-member businesses and has achieved leading Internet-based patient help and sampling of the medication world.
Each patient assistance request form is tailor-made by the medication company’s regulations search. Rx Hope is an independent company not associated with others who provide patients with low or no-cost meds. According to their website, one of the benefits of using the service is a financial savings due to less money spent on postage, printing, sorting, and other lengthy jobs. Rx Hope, a privately held company, also has an assistance finder which joins info compared with other current federal, state, and other pharmaceutical models.
One drug, Requip (Ropinirole HCL), a medication for insomnia which was approved on May 9th, is popular for the treatment of primary Restless Leg Syndrome (RLS) in adults. Symptoms include an uncomfortable feeling in the legs (tingling, creepy, itching, pulling, or aching) with an urge to move them during inactivity, including both sleep and wakefulness. The cause of RLS is unknown but researchers believe it may be related to dopamine, a chemical that carries signals between nerve cells. The approval of the drug for came after clinical trials showed it greatly reduced symptoms and improved sleep quality in adults.
For more information, call 908-713-7600 or email customerservice@rxhope.com.